TY - JOUR
T1 - Cardio-facio-cutaneous syndrome
T2 - Clinical features, diagnosis, and management guidelines
AU - Pierpont, Mary E lla M
AU - Magoulas, Pilar L.
AU - Adi, Saleh
AU - Kavamura, Maria I nes
AU - Neri, Giovanni
AU - Noonan, Jacqueline
AU - Pierpont, Elizabeth I.
AU - Reinker, Kent
AU - Roberts, Amy E.
AU - Shankar, Suma
AU - Sullivan, Joseph
AU - Wolford, Melinda
AU - Conger, Brenda
AU - Santa Cruz, Molly
AU - Rauen, Katherine A.
N1 - Publisher Copyright:
© 2014 by the American Academy of Pediatrics.
PY - 2014
Y1 - 2014
N2 - Cardio-facio-cutaneous syndrome (CFC) is one of the RASopathies that bears many clinical features in common with the other syndromes in this group, most notably Noonan syndrome and Costello syndrome. CFC is genetically heterogeneous and caused by gene mutations in the Ras/mitogen-activated protein kinase pathway. The major features of CFC include characteristic craniofacial dysmorphology, congenital heart disease, dermatologic abnormalities, growth retardation, and intellectual disability. It is essential that this condition be differentiated from other RASopathies, as a correct diagnosis is important for appropriate medical management and determining recurrence risk. Children and adults with CFC require multidisciplinary care from specialists, and the need for comprehensive management has been apparent to families and health care professionals caring for affected individuals. To address this need, CFC International, a nonprofit family support organization that provides a forum for information, support, and facilitation of research in basic medical and social issues affecting individuals with CFC, organized a consensus conference. Experts in multiple medical specialties provided clinical management guidelines for pediatricians and other care providers. These guidelines will assist in an accurate diagnosis of individuals with CFC, provide best practice recommendations, and facilitate long-term medical care.
AB - Cardio-facio-cutaneous syndrome (CFC) is one of the RASopathies that bears many clinical features in common with the other syndromes in this group, most notably Noonan syndrome and Costello syndrome. CFC is genetically heterogeneous and caused by gene mutations in the Ras/mitogen-activated protein kinase pathway. The major features of CFC include characteristic craniofacial dysmorphology, congenital heart disease, dermatologic abnormalities, growth retardation, and intellectual disability. It is essential that this condition be differentiated from other RASopathies, as a correct diagnosis is important for appropriate medical management and determining recurrence risk. Children and adults with CFC require multidisciplinary care from specialists, and the need for comprehensive management has been apparent to families and health care professionals caring for affected individuals. To address this need, CFC International, a nonprofit family support organization that provides a forum for information, support, and facilitation of research in basic medical and social issues affecting individuals with CFC, organized a consensus conference. Experts in multiple medical specialties provided clinical management guidelines for pediatricians and other care providers. These guidelines will assist in an accurate diagnosis of individuals with CFC, provide best practice recommendations, and facilitate long-term medical care.
KW - Braf mutation
KW - Cardio-facio-cutaneous syndrome
KW - Management guidelines
KW - Mek1 mutation
KW - Mek2 mutation
KW - RASopathy
UR - http://www.scopus.com/inward/record.url?scp=84925545671&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84925545671&partnerID=8YFLogxK
U2 - 10.1542/peds.2013-3189
DO - 10.1542/peds.2013-3189
M3 - Review article
C2 - 25180280
AN - SCOPUS:84925545671
SN - 0031-4005
VL - 134
SP - e1149-e1162
JO - Pediatrics
JF - Pediatrics
IS - 4
ER -